TD Waterhouse Canada’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
TD Waterhouse Canada's ABBV Position: Q1 2026 in Review
TD Waterhouse Canada increased its AbbVie (ABBV) stake by 814% in Q1 2026, buying an estimated $99.4M and bringing the position to 502,971 shares worth $108M. The position accounts for 0.32% of the portfolio, ranked #61.
TD Waterhouse Canada first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- TD Waterhouse Canada held 502,971 shares of AbbVie worth $108M as of Q1 2026.
- TD Waterhouse Canada bought 447,935 AbbVie shares in Q1 2026, an estimated $99.4M.
- AbbVie made up 0.32% of TD Waterhouse Canada's portfolio in Q1 2026, its #61 holding.
- TD Waterhouse Canada first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.